EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Influenza Vaccine Effectiveness Against Symptomatic Influenza in Primary Care: A Test Negative Case Control Study Over Two Influenza Seasons 2022/2023 and 2023/2024 in Ireland

Louise Marron iD, Adele McKenna, Joan O'Donnell, Michael Joyce, Charlene Bennett, Jeff Connell, Lisa Domegan iD

Influenza and Other Respiratory Viruses · 2024

DOI: 10.1111/irv.70023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Influenza and Other Respiratory Viruses, 2024. Verfasst von Louise Marron und 6 weiteren Autor:innen. Beteiligte Einrichtung: Health Service Executive, Health Protection Surveillance Centre, Dublin 1, Ireland. Hauptthemen laut MEDLINE: Influenza Vaccines, Influenza, Human, Primary Health Care, Vaccine Efficacy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Centre for Disease Prevention and Control.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Live attenuated influenza vaccine (LAIV) is recommended in Ireland for all children aged 2–17 years. Quadrivalent influenza vaccine (QIV) is recommended for all others eligible for vaccination, including those ≥ 18 years with underlying medical conditions and all aged ≥ 65 years. We aimed to estimate influenza vaccine effectiveness (IVE) against acute respiratory infection (ARI) presentations to primary care due to influenza over two influenza seasons in Ireland, to inform vaccination recommendations and communication campaigns.

Methods

We undertook a test‐negative case control study within the Irish sentinel general practice surveillance network as part of the Vaccine Effectiveness Burden and Impact Studies (VEBIS) network. We compared influenza vaccination status among influenza PCR positive cases with influenza PCR negative controls, both with ARI presentations, of all ages. We estimated IVE using logistic regression adjusting for age, onset time, medical conditions and sex.

Results

In 2022/2023, there were 288 cases and 765 controls. In 2023/2024, there were 567 cases and 1832 controls. In 2022/2023, overall IVE was 42% (95% CI 9 to 64) and 50% (95% CI −30 to 83) in 2‐ to 17‐year‐olds. Overall IVE in 2023/2024 was 35% (95% CI 15 to 51) and 68% (95% CI 30 to 87) in 2‐ to 17‐year‐olds.

Conclusion

Influenza vaccination reduced the risk of influenza among ARI patients presenting to general practice, demonstrating the benefits of vaccination, particularly among children. Promotion of the seasonal influenza vaccine to recommended groups, should remain a public health priority. Targeted vaccination campaigns for children promoting LAIV should emphasise the effectiveness of LAIV in children.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza VaccinesInfluenza, HumanPrimary Health CareVaccine EfficacyHumansIrelandChildCase-Control StudiesFemaleMaleAdolescentChild, PreschoolAdultYoung AdultAgedMiddle AgedVaccinationInfantSeasonsSentinel SurveillanceVaccines, Attenuated

Stichwörter der Autor:innen

LAIVinfluenzainfluenza vaccinesentinelsurveillancevaccine effectiveness

Substanzen

Influenza VaccinesVaccines, Attenuated

Autor:innen und Institutionen

  • Health Service Executive, Health Protection Surveillance Centre, Dublin 1, Ireland.
  • ECDC Fellowship Programme, Field Epidemiology Path (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Irish College of General Practitioners, Dublin 2, Ireland.
  • National Virus Reference Laboratory, University College Dublin, Dublin 4, Ireland.

ORCID-Profile: Louise Marron, Lisa Domegan

Förderung

  • European Centre for Disease Prevention and Control

Zitieren

APA

Marron, L., McKenna, A., O'Donnell, J., Joyce, M., Bennett, C., Connell, J., & Domegan, L. (2024). Influenza Vaccine Effectiveness Against Symptomatic Influenza in Primary Care: A Test Negative Case Control Study Over Two Influenza Seasons 2022/2023 and 2023/2024 in Ireland. Influenza and Other Respiratory Viruses. https://doi.org/10.1111/irv.70023

Vancouver

Marron L, McKenna A, O'Donnell J, Joyce M, Bennett C, Connell J, et al. Influenza Vaccine Effectiveness Against Symptomatic Influenza in Primary Care: A Test Negative Case Control Study Over Two Influenza Seasons 2022/2023 and 2023/2024 in Ireland. Influenza and Other Respiratory Viruses. 2024. doi:10.1111/irv.70023

BibTeX
@article{Marron2024,
  author = {Marron, Louise and McKenna, Adele and O'Donnell, Joan and Joyce, Michael and Bennett, Charlene and Connell, Jeff and Domegan, Lisa},
  title = {Influenza Vaccine Effectiveness Against Symptomatic Influenza in Primary Care: A Test Negative Case Control Study Over Two Influenza Seasons 2022/2023 and 2023/2024 in Ireland},
  journal = {Influenza and Other Respiratory Viruses},
  year = {2024},
  doi = {10.1111/irv.70023}
}
Kostenlos starten →